# ZVRA (Zevra Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Zevra Therapeutics, Inc. reported $147.8M in revenue and net income of $78.02M for the trailing twelve months ended September 30, 2026 (up 44.9% year over year), with a 95.4% gross margin and a 60.8% operating margin.

- Canonical: https://convexityos.com/fundamentals/ZVRA
- Markdown: https://convexityos.com/fundamentals/ZVRA.md
- SEC CIK: 0001434647
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:33 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001434647&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $147.8M | +44.9% YoY |
| Operating Income | TTM | $89.82M | 60.8% margin |
| Net Income | TTM | $78.02M | 52.8% net margin |
| Diluted EPS | TTM | $1.26 | Split-adjusted |
| Free Cash Flow | TTM | $38.28M | 25.9% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $195.6M | Total debt: $1.23M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $106.5M | $23.61M | $27.46M | $10.16M | $28.65M | $13.29M | $12.84M | $0 | -- | -- |
| Cost of Revenue | $16.48M | $7.42M | $2.94M | $222K | $2.06M | -- | $10.00M | $0 | -- | -- |
| **Gross Profit** | $89.99M | $16.20M | $24.52M | $9.94M | $26.59M | -- | $2.84M | $0 | -- | -- |
| Research & Development | $12.74M | $42.09M | $39.81M | $19.80M | $10.16M | $8.84M | $19.41M | $41.76M | $20.59M | $20.47M |
| Selling, General & Admin | $77.62M | $54.87M | $34.31M | $15.04M | -- | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | -- | -- | -- | -- | -- | $55.90M | $33.37M | $37.48M |
| **Operating Income** | -$62.94M | -$87.00M | -$49.60M | -$42.56M | $7.73M | -$5.61M | -$20.34M | -$55.90M | -$33.37M | -$37.48M |
| **EBITDA** | -$58.89M | -$80.61M | -$48.60M | -$41.62M | $7.99M | -$5.34M | -$20.03M | -$55.58M | -$33.03M | -$37.31M |
| Interest Expense | $7.98M | $7.35M | $1.50M | $335K | $226K | $4.79M | $4.86M | $5.47M | $5.78M | $5.51M |
| Income Before Tax | $86.68M | -$90.14M | -$46.05M | -$26.80M | -$8.52M | -$12.79M | -$24.54M | -$56.59M | -$43.43M | -$16.53M |
| Income Tax Expense | $3.45M | $15.37M | $0 | -$33K | $34K | -$34K | -$22K | -$126K | -$43K | -$15K |
| **Net Income** | $83.23M | -$105.5M | -$46.05M | -$26.77M | -$8.55M | -$12.76M | -$24.52M | -$56.47M | -$43.39M | -$16.52M |
| Basic EPS | $1.40 | -$2.28 | -$1.30 | -$0.78 | -$2.11 | -$3.21 | -$211.68 | -$50.40 | -$47.36 | -$18.08 |
| **Diluted EPS** | $1.35 | -$2.28 | -- | -- | -$2.11 | -$3.21 | -$211.68 | -$50.40 | -$47.36 | -$18.08 |
| Basic Shares Outstanding | 55.3M | 46.3M | 35.5M | 34.5M | 29.8M | 4.0M | 115.8K | 1.1M | 915.8K | 912.3K |
| Diluted Shares Outstanding | 57.3M | 46.3M | -- | -- | 29.8M | 4.0M | 115.8K | 1.1M | 915.8K | 912.3K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $37.76M | $39.66M | $36.22M | $34.12M | $26.06M | $25.88M | $20.40M | $12.04M |
| Cost of Revenue | $1.79M | $1.52M | $1.90M | $1.52M | $1.24M | $12.38M | $1.34M | $1.37M |
| **Gross Profit** | $35.96M | $38.14M | $34.32M | $32.60M | $24.82M | $13.50M | $19.06M | $10.68M |
| Research & Development | $4.94M | $4.49M | $4.39M | $2.62M | $3.43M | $3.43M | $3.26M | $8.35M |
| Selling, General & Admin | $19.13M | $16.56M | $20.78M | $20.35M | $16.93M | $20.78M | $19.55M | $16.12M |
| **Operating Income** | $11.58M | $16.78M | $52.15M | $9.31M | $4.14M | -$71.04M | -$5.36M | -$15.42M |
| **EBITDA** | $11.96M | $17.14M | $52.51M | $9.68M | $4.54M | -$69.39M | -$3.71M | -$13.77M |
| Interest Expense | $0 | $0 | $1.71M | $1.95M | $2.05M | $2.01M | $1.97M | $2.19M |
| Income Before Tax | $19.72M | $12.79M | $44.80M | $12.67M | -$977K | $76.91M | -$1.92M | -$20.37M |
| Income Tax Expense | $510K | $4.04M | $6.91M | $501K | -$433K | $2.20M | $1.18M | $15.37M |
| **Net Income** | $19.21M | $8.75M | $37.89M | $12.16M | -$544K | $74.71M | -$3.10M | -$35.74M |
| Basic EPS | $0.31 | $0.14 | $0.62 | -- | -$0.01 | $1.24 | -$0.06 | -- |
| **Diluted EPS** | $0.26 | $0.14 | $0.60 | -- | -$0.01 | $1.21 | -$0.06 | -- |
| Basic Shares Outstanding | 59.4M | 59.2M | 58.4M | -- | 56.0M | 54.8M | 54.1M | -- |
| Diluted Shares Outstanding | 61.7M | 61.3M | 60.2M | -- | 56.0M | 56.3M | 54.1M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $62.41M | $33.78M | $43.05M | $65.47M | $112.3M | $4.21M | $3.22M | $18.41M | $10.87M | $16.76M |
| Short-Term Investments | $128.6M | $35.71M | $24.69M | $16.90M | $0 | -- | -- | $3.26M | $31.36M | $51.00M |
| **Cash & Short-Term Investments** | $191.0M | $69.50M | $67.70M | $82.37M | $112.3M | $4.21M | $3.22M | $21.67M | $42.23M | $67.77M |
| Accounts Receivable, Net | -- | $10.18M | $16.12M | $7.18M | $1.42M | $2.44M | $1.68M | $0 | $2.00M | $5.00M |
| Inventory | $1.74M | $1.97M | $0 | $671K | -- | -- | -- | -- | -- | -- |
| **Total Current Assets** | $223.0M | $86.03M | $86.94M | $92.83M | $115.1M | $8.38M | $6.97M | $23.72M | $45.90M | $74.36M |
| Property, Plant & Equipment, Net | $489K | $356K | $736K | $794K | $884K | $1.04M | $1.47M | $1.75M | $2.00M | $1.97M |
| Goodwill | $4.70M | $4.70M | $4.70M | $0 | -- | -- | -- | -- | -- | -- |
| Intangible Assets | $6.42M | $68.99M | $69.23M | $0 | -- | -- | -- | -- | -- | -- |
| Long-Term Investments | $47.88M | $6.01M | $0 | $0 | $15.42M | $0 | -- | -- | $3.25M | $8.20M |
| Other Non-Current Assets | $143K | $384K | $94K | $53K | $438K | $438K | $527K | $562K | $206K | $360K |
| **Total Non-Current Assets** | $61.72M | $92.10M | $85.39M | $22.51M | $17.89M | $2.83M | $3.54M | $3.02M | $6.56M | $10.53M |
| **Total Assets** | $284.7M | $178.1M | $172.3M | $115.3M | $132.9M | $11.21M | $10.51M | $26.75M | $52.46M | $84.89M |
| Accounts Payable | $2.48M | $13.07M | $13.99M | $3.61M | $516K | $1.17M | $1.14M | $3.71M | $2.18M | $469K |
| Other Current Liabilities | $1.36M | $2.26M | $2.52M | $719K | $836K | $172K | $236K | $115K | $112K | $41K |
| **Total Current Liabilities** | $39.28M | $34.06M | $73.72M | $12.02M | $4.23M | $7.54M | $5.43M | $12.00M | $11.51M | $6.64M |
| Long-Term Debt | $61.93M | $59.50M | $5.07M | -- | -- | $67.66M | $77.34M | $81.44M | $92.73M | -- |
| Other Non-Current Liabilities | $1.71M | $4.63M | $7.46M | $25K | $31K | $145K | $168K | $689K | $794K | $496K |
| **Total Non-Current Liabilities** | $90.80M | $104.4M | $36.74M | $28.20M | $1.59M | $70.08M | $79.53M | $81.31M | $98.46M | $96.94M |
| **Total Liabilities** | $130.1M | $138.5M | $110.5M | $40.22M | $5.82M | $77.62M | $84.96M | $93.31M | $110.0M | $103.6M |
| **Total Debt (incl. Leases)** | $63.21M | $60.30M | $6.07M | $1.33M | $1.61M | $69.77M | $79.93M | $81.44M | $92.73M | -- |
| Common Stock | -- | $5.0K | $4.0K | $3.0K | $4.0K | $0 | $0 | $3.0K | $1.0K | $1.0K |
| Retained Earnings | -$422.1M | -$505.3M | -$399.8M | -$353.7M | -$267.0M | -$258.5M | -$245.7M | -$221.2M | -$164.7M | -$121.3M |
| Accumulated Other Comp. Income | -$764K | $631K | -$43K | $113K | $0 | -- | -- | -- | -- | -- |
| **Total Stockholders' Equity** | $154.7M | $39.67M | $61.86M | $75.12M | $101.7M | -$66.41M | -$74.46M | -$66.57M | -$57.52M | -$18.70M |
| Total Equity | $154.7M | $39.67M | $61.86M | $75.12M | $101.7M | -$66.41M | -$74.46M | -$66.57M | -$57.52M | -$18.70M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $122.1M | $145.3M | $95.59M | $62.41M | $54.44M | $47.71M | $37.34M | $33.78M |
| Short-Term Investments | $73.42M | $76.25M | $105.0M | $128.6M | $145.1M | $154.9M | $25.29M | $35.71M |
| **Cash & Short-Term Investments** | $195.6M | $221.6M | $200.6M | $191.0M | $199.5M | $202.6M | $62.63M | $69.50M |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | -- | -- | $10.18M |
| Inventory | $3.07M | $2.45M | $2.31M | $1.74M | $1.37M | $1.11M | $2.56M | $1.97M |
| **Total Current Assets** | $225.8M | $251.3M | $230.0M | $223.0M | $225.1M | $226.3M | $81.57M | $86.03M |
| Property, Plant & Equipment, Net | $816K | $641K | $430K | $489K | $488K | $599K | $422K | $356K |
| Goodwill | $4.70M | $4.70M | $4.70M | $4.70M | $4.70M | $4.70M | $4.70M | $4.70M |
| Intangible Assets | $5.47M | $5.79M | $6.11M | $6.42M | $6.74M | $7.05M | $67.38M | $68.99M |
| Long-Term Investments | $75.32M | $38.61M | $36.15M | $47.88M | $30.86M | $15.09M | $6.09M | $6.01M |
| Other Non-Current Assets | $0 | $3.0K | $143K | $143K | $153K | $220K | $293K | $384K |
| **Total Non-Current Assets** | $87.74M | $51.41M | $48.61M | $61.72M | $45.00M | $29.94M | $91.14M | $92.10M |
| **Total Assets** | $313.6M | $302.7M | $278.6M | $284.7M | $270.1M | $256.3M | $172.7M | $178.1M |
| Accounts Payable | -- | -- | -- | $2.48M | -- | -- | -- | $13.07M |
| Other Current Liabilities | $1.32M | $1.42M | $1.41M | $1.36M | $8.99M | $6.87M | $3.40M | $2.26M |
| **Total Current Liabilities** | $41.37M | $48.63M | $47.03M | $39.28M | $26.11M | $28.83M | $26.98M | $34.06M |
| Long-Term Debt | $0 | $0 | $0 | $61.93M | $61.31M | $60.69M | $60.09M | $59.50M |
| Other Non-Current Liabilities | $2.87M | $2.09M | $1.86M | $1.71M | $4.00M | $3.32M | $4.88M | $4.63M |
| **Total Non-Current Liabilities** | $33.28M | $36.43M | $25.75M | $90.80M | $110.8M | $110.2M | $104.7M | $104.4M |
| **Total Liabilities** | $74.65M | $85.06M | $72.78M | $130.1M | $137.0M | $139.0M | $131.7M | $138.5M |
| **Total Debt (incl. Leases)** | $1.23M | $1.50M | $1.15M | $63.21M | $62.72M | $62.28M | $61.84M | $60.30M |
| Common Stock | -- | -- | -- | -- | -- | -- | $5.0K | $5.0K |
| Retained Earnings | -$356.2M | -$375.4M | -$384.2M | -$422.1M | -$434.2M | -$433.7M | -$508.4M | -$505.3M |
| Accumulated Other Comp. Income | -$3.51M | -$2.22M | -$1.80M | -$764K | -$2.42M | -$2.43M | -$82K | $631K |
| **Total Stockholders' Equity** | $238.9M | $217.7M | $205.8M | $154.7M | $133.2M | $117.2M | $41.02M | $39.67M |
| Total Equity | $238.9M | $217.7M | $205.8M | $154.7M | $133.2M | $117.2M | $41.02M | $39.67M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $83.23M | -$105.5M | -$46.05M | -$26.77M | -$8.55M | -$12.76M | -$24.52M | -$56.47M | -$43.39M | -$16.52M |
| Depreciation & Amortization | $4.05M | $6.39M | $1.01M | $944K | $257K | $273K | $304K | $324K | $336K | $175K |
| Stock-Based Compensation | $12.63M | $14.91M | $5.95M | $4.29M | $2.44M | $2.49M | $4.41M | $6.50M | $4.56M | $6.60M |
| Change in Inventory | -$1.30M | -$8.87M | $206K | $147K | $0 | -- | -- | -- | -- | -- |
| **Operating Cash Flow** | -$1.60M | -$69.67M | -$33.53M | -$18.72M | $10.44M | -$1.94M | -$23.74M | -$54.20M | -$33.10M | -$29.77M |
| Capital Expenditure | -$835K | $0 | -$296K | -$93K | -$102K | -$33K | -$26K | -$21K | -$181K | -$643K |
| **Free Cash Flow** | -$2.43M | -$69.67M | -$33.83M | -$18.81M | $10.34M | -$1.97M | -$23.76M | -$54.22M | -$33.28M | -$30.41M |
| Acquisitions, Net | -- | $0 | -$30.40M | -$14.09M | $0 | -- | -- | -- | -- | -- |
| Purchases of Investments | -- | -- | -$45.81M | -$23.86M | -$15.42M | $0 | -- | -- | -$27.38M | -$89.85M |
| Sales & Maturities of Investments | $178.5M | $25.00M | $59.12M | $1.32M | -- | -- | -- | -- | -- | -- |
| **Investing Cash Flow** | $18.13M | -$22.16M | -$17.39M | -$36.72M | -$15.52M | -$33K | $3.23M | $33.33M | $27.41M | -$45.85M |
| Common Stock Issued | $0 | $64.52M | $6.11M | $0 | -- | -- | -- | $4.83M | -- | -- |
| Share Repurchases | -- | $0 | -$3.45M | -$4.72M | -$2.81M | $0 | -- | -- | -- | -- |
| **Financing Cash Flow** | $12.06M | $82.11M | $28.46M | $8.35M | $113.1M | $2.74M | $4.94M | $28.02M | -$203K | $61.16M |
| **Net Change in Cash** | $28.62M | -$9.26M | -$22.42M | -$46.88M | $108.0M | $767K | -$15.56M | $7.15M | -$5.89M | -$14.46M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $19.21M | $8.75M | $37.89M | $12.16M | -$544K | $74.71M | -$3.10M | -$35.74M |
| Depreciation & Amortization | $378K | $364K | $368K | $362K | $392K | $1.65M | $1.65M | $1.65M |
| Stock-Based Compensation | $2.67M | $2.97M | $3.10M | $4.28M | $2.77M | $2.46M | $3.12M | $4.02M |
| Change in Inventory | -$637K | -$140K | -$185K | -$525K | -$194K | -$381K | -$205K | -$4.71M |
| **Operating Cash Flow** | $10.05M | $17.03M | $6.14M | $5.52M | $4.71M | -$3.60M | -$8.22M | -$16.25M |
| Capital Expenditure | -$238K | -$217K | -$35K | $31K | -$554K | -$213K | -$99K | $0 |
| **Free Cash Flow** | $9.81M | $16.82M | $6.11M | $5.55M | $4.16M | -$3.81M | -$8.32M | -$16.25M |
| Sales & Maturities of Investments | $45.00M | $49.25M | $93.97M | $87.50M | $60.50M | $12.50M | $18.00M | $202K |
| **Investing Cash Flow** | -$34.85M | $31.45M | $79.62M | $227K | -$4.58M | $11.93M | $10.54M | -$5.47M |
| Common Stock Issued | -- | -- | -- | $0 | -- | -- | $0 | $0 |
| Share Repurchases | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Financing Cash Flow** | $1.55M | $1.58M | -$52.80M | $2.55M | $6.53M | $1.38M | $1.61M | $796K |
| **Net Change in Cash** | -$23.17M | $49.73M | $33.19M | $7.97M | $6.73M | $10.37M | $3.56M | -$20.25M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 84.5% | 68.6% | 89.3% | 97.8% | 92.8% | -- | 22.1% | -- | -- | -- |
| **Operating Margin** | -59.1% | -368.5% | -180.6% | -418.9% | 27.0% | -42.2% | -158.4% | -- | -- | -- |
| **Net Profit Margin** | 78.2% | -446.9% | -167.7% | -263.5% | -29.9% | -96.0% | -191.0% | -- | -- | -- |
| Return on Equity (ROE) | 53.8% | -266.0% | -74.4% | -35.6% | -8.4% | -- | -- | -- | -- | -- |
| Return on Assets (ROA) | 29.2% | -59.2% | -26.7% | -23.2% | -6.4% | -113.8% | -233.4% | -211.1% | -82.7% | -19.5% |
| Current Ratio | 5.68x | 2.53x | 1.18x | 7.72x | 27.20x | 1.11x | 1.28x | 1.98x | 3.99x | 11.19x |
| Quick Ratio | 5.63x | 2.47x | 1.18x | 7.67x | 26.90x | 0.88x | 0.90x | 1.81x | 3.84x | 10.96x |
| Debt to Equity | 0.41x | 1.52x | 0.10x | 0.02x | 0.02x | -- | -- | -- | -- | -- |
| **Revenue Growth (YoY)** | +350.9% | -14.0% | +170.3% | -64.5% | +115.6% | +3.5% | -- | -- | -- | -- |
| Gross Profit Growth (YoY) | +455.7% | -33.9% | +146.7% | -62.6% | -- | -- | -- | -- | -- | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -650.7% | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -279.3% | -- | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -282.0% | -- | -- | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | -42.3% | -99.5% | -- | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 95.4% | 95.5% | 86.1% | 84.5% | 80.7% | 72.0% | 78.8% | 68.6% |
| **Operating Margin** | 60.8% | 60.5% | -4.4% | -59.1% | -103.9% | -192.1% | -177.1% | -368.5% |
| **Net Profit Margin** | 52.8% | 42.8% | 101.6% | 78.2% | 41.9% | 4.3% | -226.6% | -446.9% |
| Return on Equity (ROE) | 32.7% | 26.8% | 60.4% | 53.8% | 26.5% | 2.3% | -224.2% | -266.0% |
| Return on Assets (ROA) | 24.9% | 19.2% | 44.6% | 29.2% | 13.1% | 1.0% | -53.3% | -59.2% |
| Current Ratio | 5.46x | 5.17x | 4.89x | 5.68x | 8.62x | 7.85x | 3.02x | 2.53x |
| Quick Ratio | 5.38x | 5.12x | 4.84x | 5.63x | 8.57x | 7.81x | 2.93x | 2.47x |
| Debt to Equity | 0.01x | 0.01x | 0.01x | 0.41x | 0.47x | 0.53x | 1.51x | 1.52x |
| **Revenue Growth (YoY)** | +44.9% | +53.3% | +77.5% | +183.4% | +605.4% | +481.7% | +495.6% | -6.8% |
| Gross Profit Growth (YoY) | +44.9% | +182.5% | +80.1% | +205.4% | +1683.4% | +1441.3% | +486.3% | -2.2% |
| Operating Income Growth (YoY) | +179.5% | -- | -- | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -88.3% | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -88.7% | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | +113.4% | -- | -- | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | +136.1% | -- | -- | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
